Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Genco Pharmaceutical Technology is a specialized biopharmaceutical company focusing on the research, development, and manufacturing of Orally Inhaled and Nasal Drug Products (OINDP). The company operates as a high-end CDMO, providing integrated services that include formulation development, device design, and large-scale manufacturing for complex inhalation therapies. Genco also maintains an internal pipeline of respiratory drugs targeting major indications like asthma and chronic obstructive pulmonary disease (COPD). By leveraging its proprietary dry powder inhaler (DPI) and metered-dose inhaler (MDI) technologies, the company aims to provide high-quality respiratory medicines to global markets. Genco is headquartered in Shanghai and maintains state-of-the-art R&D and manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Genco Pharmaceutical Technology Co., Ltd..